Huang Qifa, Wei Xin, Li Wenyu, Ma Yanbing, Chen Guanxiang, Zhao Lu, Jiang Ying, Xie Siqi, Chen Qi, Chen Tingtao
Department of Obstetrics & Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, China.
Cancers (Basel). 2022 Oct 22;14(21):5178. doi: 10.3390/cancers14215178.
The oncogenesis and progression of epithelial ovarian cancer (EOC) is a complicated process involving several key molecules and factors, yet whether microbiota are present in EOC, and their role in the development of EOC, remains greatly unknown.
In this study, 20 patients were enrolled to compare the similarities and differences of intratumour microbiota among patients with epithelial benign ovarian tumours (EBOTs) and patients with EOC based on the high-throughput sequencing method. Subsequently, we further isolated the specific EOC-related bacteria and defined as a key strain in facilitating EOC progression. More importantly, we constructed a mouse EOC model to evaluate the effect of the strain on EOC using immunohistochemistry, Western blotting, and RT-qPCR.
The high-throughput sequencing showed that the intratumour microbiota in EOC tissues had a higher microbial diversity and richness compared to EBOT tissues. The abundance of previously considered pathogens, , , , , and , was increased in the EOC tissues. Meanwhile, we discovered the facilitating role of the strain in the progression of EOC, which may be partially associated with the increased inflammatory response to activate the hedgehog (Hh) signalling pathway. This microbial-induced EOC progression mechanism is further confirmed using the inhibitor GANT61.
This study profiled the intratumour microbiota of EBOT and EOC tissues and demonstrated that the diversity and composition of the intratumour microbiota were significantly different. Furthermore, through in vivo and in vitro experiments, we confirmed the molecular mechanism of intratumour microbiota promotion of EOC progression in mice, which induces inflammation to activate the Hh signalling pathway. This could provide us clues for improving EOC treatment.
上皮性卵巢癌(EOC)的发生和发展是一个复杂的过程,涉及多个关键分子和因素,但EOC中是否存在微生物群及其在EOC发展中的作用仍不清楚。
在本研究中,招募了20名患者,基于高通量测序方法比较上皮性卵巢良性肿瘤(EBOT)患者和EOC患者肿瘤内微生物群的异同。随后,我们进一步分离出与EOC相关的特定细菌,并将其定义为促进EOC进展的关键菌株。更重要的是,我们构建了小鼠EOC模型,使用免疫组织化学、蛋白质免疫印迹法和逆转录定量聚合酶链反应来评估该菌株对EOC的影响。
高通量测序显示,与EBOT组织相比,EOC组织中的肿瘤内微生物群具有更高的微生物多样性和丰富度。在EOC组织中,先前认为的病原体、、、、和的丰度增加。同时,我们发现该菌株在EOC进展中具有促进作用,这可能部分与激活刺猬(Hh)信号通路的炎症反应增加有关。使用抑制剂GANT61进一步证实了这种微生物诱导的EOC进展机制。
本研究分析了EBOT和EOC组织的肿瘤内微生物群,表明肿瘤内微生物群的多样性和组成存在显著差异。此外,通过体内和体外实验,我们证实了肿瘤内微生物群促进小鼠EOC进展的分子机制,即诱导炎症以激活Hh信号通路。这可能为改善EOC治疗提供线索。